Loading content…
Affiliate-supportedIndependent editorialWe never sell medicationSee how
Midwest · Nebraska
Local context for Wegovy, Ozempic, Mounjaro, and Zepbound in Omaha (490,000 residents, 990,000 metro). Heritage Health (NE Medicaid expansion) covers T2D GLP-1s with prior auth; Nebraska Medicine anchors academic care.
Availability and prices vary by pharmacy and date. We do not maintain real-time per-pharmacy stock data. Confirm with pharmacies directly.
Wegovy
semaglutide · Novo Nordisk
Once-weekly semaglutide injection FDA-approved for chronic weight management in adults and adolescents.
Wegovy in Omaha →
Ozempic
semaglutide · Novo Nordisk
Once-weekly semaglutide injection FDA-approved for adults with type 2 diabetes.
Ozempic in Omaha →
Mounjaro
tirzepatide · Eli Lilly
Once-weekly tirzepatide injection FDA-approved for adults with type 2 diabetes.
Mounjaro in Omaha →
Zepbound
tirzepatide · Eli Lilly
Once-weekly tirzepatide injection FDA-approved for chronic weight management and obstructive sleep apnea.
Zepbound in Omaha →
Omaha is a midwest-region city with a population of 490,000 (990,000 in the broader metropolitan area). Nebraska expanded Medicaid under the Affordable Care Act, which means low-income adults can typically qualify for GLP-1 coverage for type 2 diabetes if the state Medicaid program lists the drug.
Statewide, notable health systems include Nebraska Medicine, CHI Health.
Nebraska's Medicaid program is Nebraska Medicaid (Heritage Health). Coverage rules for GLP-1 medications vary by drug and indication; see our pricing by state map and payer-coverage guides for details.
Cities of similar size with comparable healthcare markets.